ReviewBiomedicines2022

Recent Advances of Immune Checkpoint Inhibition and Potential for (Combined) TIGIT Blockade as a New Strategy for Malignant Pleural Mesothelioma.

Sophie Rovers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.